Clinical Trial Update: Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing azimilide and sotalol to placebo in patients with atrial fibrillation to evaluate efficacy and safety; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Azimilide (azimilide)
• Sotalol (Sotalol)

Snippet

Sponsor: Forest Laboratories | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED